Sino Biological, Inc. has announced the accelerated availability and development of critical research tools to support the global scientific community in combating NiV.
When you buy shares in a company, there is always a risk that the price drops to zero. But if you pick the right business to buy shares in, you can make more than you can lose. For example, the ...
Hong Kong-listed Sino Biopharmaceutical will acquire China-based oncology specialist LaNova Medicines in a deal that will not exceed $951m, representing one of the largest transactions within the Asia ...
Sino Biological, a biotechnology company which provides biological research reagents and related technical contract research services, announced a successful listing on the Shenzhen Stock Exchange ...
Sino Biological, Inc. (“Sino Biological” or the “Company”), is pleased to announce the formal opening of its new Center for Bioprocessing (C4B) in Houston, Texas USA at Levit Green, adjacent to the ...
Sino Biopharmaceutical Ltd. operates as an investment holding company, which engages in the manufacturing and selling of pharmaceutical products. The company operates through the following business ...
Your one-stop source for comprehensive reagent solutions and CRO services Sino Biological, an international reagent supplier and service provider, specializes in recombinant protein production and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results